References
- Thomas ED, Buckner CD, Banaji M, et al. One-hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 1977; 49:511–33.
- Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation. N Engl J Med 1975;292:895–902.
- Philip T, Armitage JO, Spitzer G, et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional therapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma. N Engl J Med 1987;316:1493–8.
- Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high dose chemotherapy for malignancies. Blood 1991;77:211–3.
- Stroncek D, Bartsch G, Perkin HA, et al. The National Marrow Donor Program. Transfusion 1993;33:567–77.
- Mavroudis D, Read EJ, Cuttler-Fox M, et al. CD34+ cell dose predicts survival, transplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996;88:3223–9.
- Szczepiorkowski ZM, ed. Standards for cellular therapy products and services. Bethesda: American Association of Blood Banks, 2004.
- Warkentin PI, ed. Standards for hematopoietic progenitor cell collection, processing and transplantation. 2nd ed. Omaha, NE: Foundation for the Accreditation of Cellular Therapy, 2002.
- Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174–8.
- Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157–66.
- Kolb H, Mittermüller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic lymphocytic leukemia in marrow transplant patients. Blood 1990;76:2462–5.
- Current Good Tissue Practice for Human Cellular and Tissue-Based Products and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement, 69 Federal Register 68611 (2004) (codified at 21 CFR Parts 16, 1270, and 1271). http://www.fda.gov/cber/rules/gtp.pdf.
- 21 CFR 1271.1 (b) (2)